Summary of Purpose
To evaluate whether there is a difference in symptomatic thromboembolism events in the subset of patients with a history of, or risk factors for thromboembolic disease for topically applied tranexamic acid in total joint arthroplasty.Read More →
The following dates are available for this trial. Trial information last updated on 22 January 2017.
|1 Feb 2016||30 Dec 2015||1 Jan 2019||1 Jan 2019||1 Dec 2015||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Conditions See All
- Ferdinand Chan
email@example.com (347) 577-4410